Effects of Lactobacillus plantarum 15-1 and fructooligosaccharides on the response of broilers to pathogenic Escherichia coli O78 challenge

PLoS One. 2019 Jun 13;14(6):e0212079. doi: 10.1371/journal.pone.0212079. eCollection 2019.

Abstract

One-day-old broilers were randomly allocated to five treatment groups: basal diet and orally administered sterile saline (negative control, n-control); basal diet challenged with E. coli O78 (positive control, p-control); basal diet supplemented with 1×108 CFU/kg L. plantarum 15-1 and challenged with E. coli O78 (LP); basal diet supplemented with 5 g/kg fructooligosaccharides (FOS) and challenged with E. coli O78 (FOS); and basal diet supplemented with both L. plantarum 15-1 and FOS and challenged with E. coli O78 (LP+FOS). The broilers in the LP, FOS, and LP+FOS groups displayed a decrease of crypt depth at day 14 compared with the control groups. Furthermore, at days 14 and 21, the broilers in the LP group exhibited reduced serum levels of diamine oxidase (DAO) compared with the p-control group (p<0.05), and the broilers in the LP+FOS group showed increased serum concentrations of IgA and IgG relative to both control groups and decreased DAO levels compared with the p-control group (p<0.05). Moreover, the LP group displayed higher levels of acetic acid and total short-chain fatty acids (SCFAs) compared with the p-control group at day 14 (p<0.05), and the FOS group showed higher levels of valeric acid and total SCFAs at day 21 (p<0.05). The LP+FOS group also displayed a higher level of butyric acid at day 14 (p<0.05). In conclusion, dietary supplementation with FOS improved the growth performance, while supplementation with L. plantarum 15-1 and FOS improved intestinal health by increasing the levels of SCFAs and mitigating the damage caused by E. coli O78, thus preventing intestinal damage and enhancing the immune response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn / growth & development
  • Animals, Newborn / immunology
  • Chickens / growth & development
  • Chickens / immunology
  • Chickens / microbiology
  • Dietary Supplements
  • Escherichia coli / drug effects*
  • Escherichia coli Infections / prevention & control
  • Fatty Acids, Volatile / blood
  • Immunity / drug effects
  • Intestines / drug effects
  • Intestines / injuries
  • Lactobacillus plantarum*
  • Oligosaccharides / pharmacology*
  • Poultry Diseases / prevention & control
  • Poultry Diseases / therapy*
  • Probiotics / pharmacology*

Substances

  • Fatty Acids, Volatile
  • Oligosaccharides
  • fructooligosaccharide

Grants and funding

This study was supported by National Natural Science Foundation of China (No. 31772642, 31672457), Beijing Agriculture Innovation Consortium 04-2018 (BAIC04-2018), National Key Research and Development Program of China (2016YFD0500504, 2016YFD0501201), Ministry of Agricultural of the People's Republic of China (2015-Z64, 2016-X47), and Hunan Provincial Science and Technology Department (2017NK2322, 2016NK2101, 2016WK2008, 2016TP2005) to SD. The authors acknowledge the academy of science and technology of state administration of grain for their support to the study.